INT236872

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.16
First Reported 2006
Last Reported 2008
Negated 1
Speculated 0
Reported most in Body
Documents 6
Total Number 6
Disease Relevance 6.52
Pain Relevance 1.14

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (BPHL) cellular amino acid metabolic process (BPHL)
Anatomy Link Frequency
neuromuscular junctions 1
BPHL (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 11 99.04 Very High Very High Very High
Botox 112 98.26 Very High Very High Very High
Prostatitis 3 94.92 High High
chronic pain syndrome 2 93.84 High High
Onset of action 2 90.28 High High
Central nervous system 2 88.28 High High
withdrawal 4 66.84 Quite High
antagonist 24 62.88 Quite High
Neurotransmitter 10 5.00 Very Low Very Low Very Low
cINOD 7 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Benign Prostatic Hypertrophy 354 100.00 Very High Very High Very High
Overactive Bladder 270 100.00 Very High Very High Very High
Lower Urinary Tract Symptoms 76 99.96 Very High Very High Very High
INFLAMMATION 12 99.04 Very High Very High Very High
Coronary Artery Disease 4 96.00 Very High Very High Very High
Frailty 8 95.44 Very High Very High Very High
Complex Regional Pain Syndromes 2 93.84 High High
Disease Progression 13 93.52 High High
Ataxia 2 90.88 High High
Urinary Tract Infection 17 72.08 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The following factors were thought to be responsible for the occurrence of AUR in BPH.
Regulation (responsible) of BPH associated with benign prostatic hypertrophy and overactive bladder
1) Confidence 0.16 Published 2007 Journal Indian Journal of Urology : IJU : Journal of the Urological Society of India Section Body Doc Link PMC2721562 Disease Relevance 2.19 Pain Relevance 0.27
They noted that the use of an A1B with the lowest risk of vascular-related adverse events is advisable for symptomatic older patients in order to ensure safe and effective BPH/LUTS treatment and to improve patient outcomes (51).
Regulation (effective) of BPH associated with benign prostatic hypertrophy and lower urinary tract symptoms
2) Confidence 0.13 Published 2008 Journal International Journal of Clinical Practice Section Body Doc Link PMC2658011 Disease Relevance 0.67 Pain Relevance 0
Effects on AUR and BPH-related surgery
Regulation (Effects) of BPH-related associated with benign prostatic hypertrophy and overactive bladder
3) Confidence 0.05 Published 2008 Journal International Journal of Clinical Practice Section Body Doc Link PMC2440415 Disease Relevance 0.71 Pain Relevance 0
Effects on AUR and BPH-related surgery
Regulation (Effects) of BPH-related associated with benign prostatic hypertrophy and overactive bladder
4) Confidence 0.05 Published 2008 Journal International Journal of Clinical Practice Section Body Doc Link PMC2440415 Disease Relevance 0.87 Pain Relevance 0.09
Recent studies have suggested that BTA is able to be used as an alternative treatment for BPH, and it is effective enough to control both mechanical and dynamic components of BPH.5,6 These suggestions are based on studies which concluded that chemical denervation using BTA causes subsequent atrophy of the gland,5 that cholinergic stimulation causes prostatic stromal smooth muscle contraction,7 and that BTA blocks acetylcholine release at the neuromuscular junctions and in autonomic neurons.
Regulation (control) of BPH in neuromuscular junctions associated with benign prostatic hypertrophy, frailty and botox
5) Confidence 0.04 Published 2006 Journal Yonsei Medical Journal Section Body Doc Link PMC2687757 Disease Relevance 1.42 Pain Relevance 0.60
All patients showed no improvement of BPH related evaluation values during the follow-up period.
Neg (no) Regulation (values) of BPH associated with benign prostatic hypertrophy
6) Confidence 0.03 Published 2006 Journal Yonsei Medical Journal Section Body Doc Link PMC2687757 Disease Relevance 0.67 Pain Relevance 0.19

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox